-+ 0.00%
-+ 0.00%
-+ 0.00%
ZnSe REPLACEMENT OPTICS FOR LEGACY CO₂ MEDICAL MARKING LASERS
Share
Listen to the news

PROVIDENCE, R.I., Nov. 10, 2026 /PRNewswire/ -- Laser Research Optics November 10, 2026 has introduced a line of replacement ZnSe optics for older CO2 laser systems used to mark and engrave metal medical and surgical devices, instruments, and components.

Laser Research ZnSe Optics are ideally suited as field-replacement parts for installed legacy CO2 laser marking systems operating in the 9 – 11 µm wavelength region and are available as focusing lenses, mirrors, and custom optical components.

Laser Research ZnSe Optics are ideally suited as field-replacement parts for installed legacy CO2 laser marking systems operating in the 9 – 11 µm wavelength region. Fully OEM compatible, they are offered in 0.5" to 1.5" sizes with focal lengths from 1" to 25" in 0.5" increments and feature coatings with < 0.2% total absorption values.

Offered for users of older laser marking equipment where original replacement optics may be difficult to obtain, Laser Research ZnSe Optics are available as focusing lenses, mirrors, and custom optical components. They are suitable for systems used to permanently mark medical metal parts and materials required for identification and traceability.

Laser Research ZnSe Optics are priced depending upon size, and quantity; available from stock.

For more information contact:

Laser Research Optics

A Division of Meller Optics, Inc.

Scott Rouillard, Sales Mgr.

120 Corliss St.

Providence, RI 02904

(888) 239-5545 FAX (401) 331-4004

e-mail: scott@laserresearch.net

www.laserresearch.net

Factory Direct Replacement Optics

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/znse-replacement-optics-for-legacy-co-medical-marking-lasers-302934296.html

SOURCE Laser Research Optics

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending